1. International Conference on Harmonization of Technical Requirement for Registration of Pharmaceuticals for Human Use 1997.https://database.ich.org/sites/default/files/Q5D_Guideline.pdf(accessed: December 2019).
2. Guideline on development production characterisation and specifications for monoclonal antibodies and related products EMEA/CHMP/BWP/157653 Committee for Medical Products for Human Use European Medicines Agency London December.2007.
3. R.Novak Regulatory perspective on the evaluation of clonality of mammalian cell banks CDER/OPQ/OBP/DBRRI 2017.https://cdn.ymaws.com/www.casss.org/resource/resmgr/cmc_no_am_jan_spkr_slds/2017_CMCJ_Novak_Rachel.pdf(accessed: December 2019).
4. Beating the odds: The poisson distribution of all input cells during limiting dilution grossly underestimates whether a cell line is clonally-derived or not
5. Considering “clonality”: A regulatory perspective on the importance of the clonal derivation of mammalian cell banks in biopharmaceutical development